
|Articles|October 6, 2003
Extended-cycle OC offers more convenience
Clinicians can soon offer women the convenience of an extended-cycle oral contraceptive (OC). The FDA recently approved levonorgestrel/ethinyl estradiol (Seasonale, Barr Laboratories) 0.15 mg/0.03 mg tablets for the prevention of pregnancy. The manufacturer plans a November 1 launch for Seasonale, the first extended-cycle OC to receive FDA approval.
Advertisement
Newsletter
Pharmacy practice is always changing. Stay ahead of the curve with the Drug Topics newsletter and get the latest drug information, industry trends, and patient care tips.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Drug Topics
1
FDA Enforces Stricter Vaccine Development, Linking COVID Vaccine to Pediatric Deaths
2
TrumpRx Promising Direct-to-Consumer Drugs for Discounted Prices
3
PCVs Significantly Reduce Pneumococcal Meningitis in Children
4
The Regimen: Pharmacists Bridging the Treatment Gap for Patients with OUD
5





































































































































